Abstract
Purpose
This study was conducted to evaluate relevant new information about ADRs reported in the Spanish paediatric population over a 6-year period.
Methods
Adverse drug reactions (ADRs) for individuals aged 0–17 years reported to the Spanish Pharmacovigilance System from 2004 to 2009 were analysed with respect to time, age and sex, category of ADR [System Organ Class (SOC)], seriousness, suspected medicines [level 2 of the Anatomical Therapeutic Chemical (ATC) Classification System] and type of reporter.
Results
In total, 4,279 ADR reports corresponding to 8,196 ADRs were analysed, approximately two ADRs per report. The rate of paediatric ADR reports in 2009 was 165 per million, of which nearly half (46 %) were for children (age group 2–11 years). Similar total numbers of ADRs were reported for boys and girls. The most frequent ADRs reported were from the following SOCs: general disorders and administration site conditions (34 %); skin and subcutaneous tissue disorders (15 %); nervous system disorders (14 %). Reports encompassed medicines from various ATC groups: vaccines and anti-infectives for systemic use (67 %); nervous system (9 %); respiratory system (9 %). On average, 37 % of ADRs were classified as serious. There were 33 fatal ADRs, and 35 % of the paediatric population associated with the ADR notifications required hospitalization or extended hospital stay.
Conclusions
In Spain, ADR reporting rate in the paediatric population has increased since 2004. The proportion of suspected ADR reports related to vaccines was predominant, which highlights the important role played by nurses. ADR notification of congenital malformations in newborn infants highlights the need for joint action between the Spanish System of Pharmacovigilance of Medicines for Human Use (SEFV-H) and paediatricians, obstetricians and gynaecologists. The publication of safety reports by regulatory agencies is determinant for the increased number of ADR notifications.
Similar content being viewed by others
References
Sturkenboom M, Verhamme K, Nicolosi A, Murray M et al (2008) Drug use in children: cohort study in three European countries. Br Med J 337:a2245
Choonara I, Gill A, Nunn A (1996) Drug toxicity and surveillance in children. Br J Clin Pharmacol 42(4):407–410
Choonara I (2000) Clinical trials of medicines in children. Br Med J 321(7269):1093–1094
Clavenna A, Bonati M (2009) Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child 94:724–728
Jonville-Bera A, Giraudeau B, Blanc P, Beau-Salinas F, Autret-Leca E (2002) Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 53:207–210
Temple M, Robinson R, Millar J, Hayes J, Nahata M (2004) Frequency and preventiability of adverse drug reactions in paediatric patients. Drug Saf 27(11):819–829
Kimlnad E, Rane A, Ufer M, Panagiotidis G (2005) Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 14:493–499
Aagaard L, Blicher C, Holme E (2010) Adverse drug reactions in paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Safety 33(4):327–339
Cheng K, Masters S, Stephenson T, Cooke R, Ferner R, Ashworth M, Nunn A (2008) Identification of suspected fatal adverse drug reactions by paediatricians: a UK surveillance study. Arch Dis Child 93:609–611
Morales-Olivas FJ, Martínez-Mir I, Ferrer JM, Rubio E, Palop V (2000) Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 53(10):1076–1080
Manso G, Hidalgo A, Carvajal A, De Abajo FJ (2010) Los primeros 25 años del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano. Ediciones de la Universidad de Oviedo, Oviedo
Clarkson A, Conroy S, Burroughs K, Choonara I (2004) Surveillance for adverse drug reactions in children: a paediatric regional monitoring centre. Paediatr Perinat Drug Ther 6:20–23
Clarkson A, Choonara I (2002) Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 87:462–467
Acknowledgements
This study was funded by the public Foundation: Fundación Canaria de Investigación y Salud (FUNCIS), PI 40/06.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aldea, A., García Sánchez-Colomer, M., Fernández Quintana, E. et al. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Eur J Clin Pharmacol 68, 1329–1338 (2012). https://doi.org/10.1007/s00228-012-1255-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1255-0